@article{e53f5af8bf9c487f8cfbc0a284b8d132,
title = "The microbiome: A target for Alzheimer disease?",
author = "Seo, \{Dong oh\} and Boros, \{Benjamin D.\} and Holtzman, \{David M.\}",
note = "Funding Information: Competing interests: David M. Holtzman is a co-founder of C2N Diagnostics LLC. He is on the scientific advisory board of Genentech, Denali, and C2N Diagnostics. He consults for Idorsia. His lab receives research grants from the National Institutes of Health, Cure Alzheimer{\textquoteright}s Fund, Tau Consortium, the JPB Foundation, and C2N Diagnostics.",
year = "2019",
month = oct,
day = "1",
doi = "10.1038/s41422-019-0227-7",
language = "English",
volume = "29",
pages = "779--780",
journal = "Cell Research",
issn = "1001-0602",
number = "10",
}